Letters to the Editor

Effects of secondary factor VIII prophylaxis on joint and bone health in a hemophilia A mouse model

Department of Hematology, Hemostasis, Oncology, and Cell Therapy, Hannover Medical School, Hannover, Germany; Institute of Clinical Chemistry and Central Laboratory, Hannover Medical School, Hannover, Germany; Preclinics GmbH, Potsdam
Swiss Center for Musculoskeletal Biobanking, Balgrist Campus AG, Zurich, Switzerland; Department of Health Science and Technology, ETH Zurich, Zurich, Switzerland; Department of Orthopedics, Balgrist University Hospital Zürich, University of Zurich, Zurich,
Department of Hematology, Hemostasis, Oncology, and Cell Therapy, Hannover Medical School, Hannover
Department of Hematology, Hemostasis, Oncology, and Cell Therapy, Hannover Medical School, Hannover
Preclinics GmbH, Potsdam
Berlin Institute of Health (BIH) at Charité, Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Berlin, Germany; Institute of Active Polymers, Helmholtz-Zentrum Hereon, 14513 Teltow
Institute of Clinical Chemistry and Central Laboratory, Hannover Medical School, Hannover
Swiss Center for Musculoskeletal Biobanking, Balgrist Campus AG, Zurich,
Institute of Clinical Chemistry and Central Laboratory, Hannover Medical School, Hannover
Department of Hematology, Hemostasis, Oncology, and Cell Therapy, Hannover Medical School, Hannover, Germany; Institute of Clinical Chemistry and Central Laboratory, Hannover Medical School, Hannover
Haematologica Early view Oct 15, 2026 https://doi.org/10.3324/haematol.2026.301495